Bonalive is a smart biomaterials company transforming the future of healthcare. With one of the most evidence-based technologies in the industry, we are creating a smarter future for healthcare. Bonalive is an ISO 13485:2016 certified, Class III medical device company.


Management team

Founder and Chief Executive Officer

Dr. Ollila founded Bonalive Biomaterials Ltd in 2009, through an MBO of the Bonalive® technology from Vivoxid Ltd. Before he became Chairman and CEO, he completed a post-doc and worked in project management at Novartis Pharma in Switzerland. In addition, Dr. Ollila was also the Global Director of Sales and Marketing at Vivoxid Ltd. He holds a PhD in biochemistry and has an international background, having lived in Finland, Spain, Switzerland and the USA.

Chief Technology Officer

Mr. Lucchesi holds a Bachelor of Science in Engineering and joined Bonalive in 2009, after holding several positions as a Research Scientist, Business Development Manager and R&D Manager in different organizations. He has thorough knowledge of the Bonalive technologies and brings his vast experience to the company. Mr. Lucchesi coordinates Bonalive’s scientific projects and oversees their technological development.

Operations Director

Mrs. Rantala joined Bonalive in 2009 after having held several positions in R&D, quality control and project management. A process-oriented thinker, Rantala believes in a lean working philosophy and mentor-based leadership. She holds a degree in laboratory sciences and is a member of the Finnish Production Management Association.

Marketing Director

Mrs. Lumiainen joined Bonalive in 2009, after having worked for Vivoxid Ltd since 2002. She has vast experience in marketing and product management, brand design and HR tasks. She holds a Master of Science in Social Sciences and Bachelor of Science in Business Administration.

Finance Director

Ms. Valtanen joined Bonalive in 2011 adding her significant experience in project management, corporate financing and accounting to the company. Ms. Valtanen holds a Master of Science in Economics and Business Administration.

Currently on maternity leave

Board of Directors

Chairman of the Board

Dr. Ollila has served as Member of the Board of Directors since 2009 and assumed the role of Chairman of the Board in 2018. He founded Bonalive Biomaterials Ltd in 2009 through a management buy-out of the Bonalive® technology from Vivoxid Ltd. Before his current position as a Chairman and CEO of Bonalive, Dr. Ollila completed a post-doctoral thesis and worked at Novartis Pharma in Switzerland for several years. He was also the Global Director of Sales and Marketing at Vivoxid Ltd. Ollila holds a doctorate in biochemistry from Åbo Akademi University.

Member of the Board

Assoc. Prof. Frantzén has been a Member of the Board of Directors since 2013. As a consultant neurosurgeon and Associate Professor at the Turku University Hospital, Frantzén has extensive experience in the clinical use of bioactive glass in spine surgery. Frantzén holds a PhD in Neurosurgery from the University of Turku.

Member of the Board

Mr. Muñoz has been a Member of the Board of Directors since 2017. He has extensive international experience from China, India and Colombia. Currently he serves as a New Business Manager (NBO) and Business Development Director at Avalon Pharmaceuticals.

Member of the Board

Mr. Rönnlund was appointed to the Board of Directors in 2019. As a marketing and sales executive in the US and Europe, he has extensive experience from Go-To-Market strategies and brand creation. Mr. Rönnlund holds an MSc in Engineering and an MSc in Economics from Åbo Akademi University.

Member of the Board

Mr. Kurokallio was appointed to the Board of Directions in 2020. He has vast experience from working with strategic positions such as the Partner and CEO of Aura Capital, CEO of Stick Tech, Partner of Greenstep and CFO of BCB Medical. Currently he is the General Manager of GC Nordic Ab.


Indication of the month (September): Trauma

September 1, 2020 12:25

The Bonalive® granules product maintains its volume effectively, naturally stimulates bone formation and inhibits bacterial growth. The granules can be used in large defects, such as post-traumatic cases of infection,...

The Bonalive story

August 26, 2020 16:14

Did you know that the idea of making glass into bone was already invented in the 1960s? Read the full story behind Bonalive bioactive glass here.

Indication of the month (August)

August 15, 2020 08:00

An easy-to-use, highly moldable biomaterial for bone regeneration, Bonalive® putty is ideally used as an autograft expander in spine fusion surgery. The Bonalive® putty MIS delivery system enables easy and...

Patient case: Chronic bone infection

June 26, 2020 08:25

A 13 year old boy was diagnosed with chronic osteomyelitis in the distal tibia. He was operated 8 times and received a large amount of antibiotics and painkillers, but the...

Message from the CEO: Gearing up for a new normal

June 23, 2020 12:49

At Bonalive, we have focused our activities these last few months on targeted projects to redefine our approach to the realities brought about by COVID-19. Our most critical services in...

Video library

May 25, 2020 15:01

Get access to the following videos: scientific presentations surgical techniques interviews with surgeons webinars

Brochure library

May 15, 2020 13:31

Read our indication-specific brochures, including: – product and technology overview – clinical areas of use – patient cases

Mitteilung des Geschäftsführers

March 27, 2020 17:11

Während ich dieses Schreiben aufsetze, sind wir weit davon entfernt, Schlussfolgerungen hinsichtlich der globalen Auswirkungen, die das Virus zeitigen wird, zu ziehen. Es wird jedoch mit aller Deutlichkeit klar, dass...

Messaggio dal CEO

March 27, 2020 16:20

Mentre vi scrivo, è troppo presto per trarre conclusioni di ampia portata sugli effetti globali del virus. Ciò che è chiaro, tuttavia, è che, come è già successo in passato,...

Message du PDG

March 27, 2020 16:19

En écrivant ces mots, il est bien trop tôt pour tirer des conclusions de grande portée sur les effets globaux du virus. Par contre, ce qui est sûr, c’est que...

Mensaje del CEO

March 27, 2020 16:09

En el momento en que escribo estas líneas, aún es demasiado pronto para sacar conclusiones de mayor proyección sobre los efectos globales del virus. Sin embargo, lo que sí está...

Mensagem do CEO

March 27, 2020 16:07

Enquanto escrevo este texto, sei que é muito cedo para tirar conclusões em longo prazo sobre os efeitos globais do vírus. O que é evidente, porém, é que, como já...

Message from the CEO

March 25, 2020 14:29

Read in Italian (Messaggio dal CEO) Read in French (Message du PDG) Read in Spanish (Mensaje del CEO) Read in Portuguese (Mensagem do CEO) Read in German (Mitteilung des Geschäftsführers)...

Bonalive Gold Sponsor of ESTROT 2020

February 17, 2020 12:56

As the Gold Sponsor of the ESTROT 2020 congress, Bonalive will host a medical expert symposium in Maastricht. The speaker line-up includes internationally renowned medical specialists within septic bone surgery:...

Septic non-union whitepaper

February 7, 2020 13:48

To give detailed guidance on the treatment of septic non-unions with Bonalive® granules (S53P4), we are now sharing the case catalog as a whitepaper. Fill out your contact details below...

Bonalive at EUROSPINE 2019

June 6, 2019 11:30

 Broadcast starts here on October 16 12:00 UTC +3h (Helsinki) In case you cannot access the stream, please check the following: – Your internet connection – Your browser (recommended:...

10 years of Smart Healing

10 years of Smart Healing

February 13, 2019 09:10

Patient stories Story 1: The ski girl “We might have to amputate your leg.” This is the message a young woman of 18 received after being seriously injured in a...

Smart Healing - Our Promise

Read more about Smart Healing™

February 13, 2019 09:09

As the world seeks answers to the growing threat of antibiotic resistance, Smart Healing™ stands for Bonalive’s commitment to our customers. It’s what can be expected from us time and...

Bonalive Youtube

Bonalive is now on YouTube

February 12, 2019 11:50

Receive instant updates on new videos by subscribing to our channel. We will share the latest congress presentations, surgical technique videos and much more on a regular basis through our...

Bonalive Medical education events flyer 2019

Bonalive events 2019 – Meet us here

January 3, 2019 16:25

The Bonalive medical education 2019 flyer provides an overview of the main congresses at which we will display our Smart Healing™ solutions during 2019. Please also take a look at...



Bonalive Biomaterials Ltd
Tel. +358 401 77 44 00
Biolinja 12, 20750 Turku, Finland


ISO 13485:2016 certified

Bonalive® granules, Bonalive® putty and Bonalive® putty MIS are CE marked products.